Table 2 CAFÉ study participant timeline
Pre-screening | Day 0 | Day 7 | Day 10 | Day 90 | Day 91 | Day 150 | Day 180 | Day 365 | |
|---|---|---|---|---|---|---|---|---|---|
EHR review eligibility | X | ||||||||
Informed consent | X | ||||||||
Randomization | X | ||||||||
Baseline data collection | X | ||||||||
Outcome evaluation | |||||||||
Participant-reported outcomes | X | ||||||||
EHR outcomes | X | X | |||||||
Intervention activities | |||||||||
Enhanced usual care activities | X | ||||||||
Navigation visit (Arm 2) | X | ||||||||
Navigation visit (Arm 3) | X | X | X | ||||||
Participant-initiated navigation (Arm 2, Arm 3) | X | X | X | X | |||||
Closure contact (Arm 2, Arm 3) | X | ||||||||
Adverse events reporting | X | X | X | X | X | X | X | X | |